Meropi A Athanasiou

Title: Meropi A Athanasiou: Innovator in Tumorigenicity Reduction

Introduction

Meropi A Athanasiou is a distinguished inventor based in Frederick, MD (US). She has made significant contributions to the field of genetics, particularly in the area of tumorigenicity reduction. With a total of 2 patents, her work has the potential to impact cancer research and treatment.

Latest Patents

Athanasiou's latest patents include innovations related to the ETS2 repressor factor (ERF). The first patent focuses on the ERF gene and its encoded products, detailing DNA sequences that encode ERF and AERF. It also covers polypeptides encoded by these sequences, ERF chimeric molecules, and methods for using these molecules to reduce tumorigenicity in tumor cells. The second patent similarly addresses the ERF genetic locus and its products, emphasizing the same applications and methodologies.

Career Highlights

Throughout her career, Athanasiou has worked with notable organizations, including the United States of America as represented by the Department of Health and the National Institutes of Health, a component of the US Department of Health & Human Services. Her work in these institutions has allowed her to contribute to significant advancements in health and medicine.

Collaborations

Athanasiou has collaborated with esteemed colleagues such as George J Mavrothalassitis and Donald G Blair. These partnerships have further enriched her research and innovation efforts.

Conclusion

Meropi A Athanasiou is a prominent figure in the field of genetics, with her patents paving the way for advancements in cancer treatment. Her contributions are invaluable to the scientific community and hold promise for future innovations.